Molecular basis of triple negative breast cancer and implications for therapy.
about
MiRNAs and Other Epigenetic Changes as Biomarkers in Triple Negative Breast CancerExploring circulating micro-RNA in the neoadjuvant treatment of breast cancerNovel genes associated with lymph node metastasis in triple negative breast cancerProtein tyrosine phosphatase UBASH3B is overexpressed in triple-negative breast cancer and promotes invasion and metastasis.The impact of Thr91 mutation on c-Src resistance to UM-164: molecular dynamics study revealed a new opportunity for drug design.Wnt signaling in triple negative breast cancer is associated with metastasisDipalmitoylphosphatidic acid inhibits tumor growth in triple-negative breast cancerCdc20 and securin overexpression predict short-term breast cancer survival.PKCλ/ι signaling promotes triple-negative breast cancer growth and metastasisCancer progression modeling using static sample dataSynthetic lethal interactions between EGFR and PARP inhibition in human triple negative breast cancer cellsA molecular analysis provides novel insights into androgen receptor signalling in breast cancer.MEL-18 loss mediates estrogen receptor-α downregulation and hormone independence.MixChIP: a probabilistic method for cell type specific protein-DNA binding analysis.Racial differences in outcomes of triple-negative breast cancerPKCζ Promotes Breast Cancer Invasion by Regulating Expression of E-cadherin and Zonula Occludens-1 (ZO-1) via NFκB-p65.An essential role of metalloprotease-disintegrin ADAM12 in triple-negative breast cancerLapatinib increases motility of triple-negative breast cancer cells by decreasing miRNA-7 and inducing Raf-1/MAPK-dependent interleukin-6.Gold Nanoantenna-Mediated Photothermal Drug Delivery from Thermosensitive Liposomes in Breast Cancer.New insights into the prognostic value of Ki-67 labeling index in patients with triple-negative breast cancerThe potential role of nanotechnology in therapeutic approaches for triple negative breast cancer.5-FU and ixabepilone modify the microRNA expression profiles in MDA-MB-453 triple-negative breast cancer cellsWnt-beta-catenin pathway signals metastasis-associated tumor cell phenotypes in triple negative breast cancers.Integrative exploration of genomic profiles for triple negative breast cancer identifies potential drug targets.CARP-1 functional mimetics are novel inhibitors of drug-resistant triple negative breast cancers.Lapatinib-induced NF-kappaB activation sensitizes triple-negative breast cancer cells to proteasome inhibitors.Breast tumor subgroups reveal diverse clinical prognostic power.Triple-negative breast cancer: future prospects in diagnosis and management.The role of PRMT1 in EGFR methylation and signaling in MDA-MB-468 triple-negative breast cancer cells.Double gene siRNA knockdown of mutant p53 and TNF induces apoptosis in triple-negative breast cancer cells.Identification of genetic determinants of breast cancer immune phenotypes by integrative genome-scale analysis.Synthesis, molecular modeling, and biological evaluation of novel RAD51 inhibitors.Theranostic Gold Nanoantennas for Simultaneous Multiplexed Raman Imaging of Immunomarkers and Photothermal TherapySurvival and local control rates of triple-negative breast cancer patients treated with boost-IOERT during breast-conserving surgery.Morgana acts as a proto-oncogene through inhibition of a ROCK-PTEN pathway.Anti-tumorigenic effects of a novel digitoxin derivative on both estrogen receptor-positive and triple-negative breast cancer cells.EGFR conjunct FSCN1 as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer.Emergence of a Promising Lead Compound in the Treatment of Triple Negative Breast Cancer: An Insight into Conformational Features and Ligand Binding Landscape of c-Src Protein with UM-164.Reversal of drug-resistance by noscapine chemo-sensitization in docetaxel resistant triple negative breast cancer.Establishment of two basal-like breast cancer cell lines with extremely low tumorigenicity from Taiwanese premenopausal women.
P2860
Q26775086-97F4EDD3-83C3-40A0-BF1B-B6FB5C7A69C0Q28066481-55D9FD70-2F4B-44BD-9B59-ECC2E127E1DCQ28393204-EF71CDAD-BE0A-4E8A-B74F-13B4B8338EBFQ30009828-CF1DA64F-8722-42F6-BEAF-D64FA2E00CA9Q30401596-8D9FA571-7212-4DE0-912D-A53638782926Q30597238-08697F95-1D6E-44C5-AFC9-D042EEF2F91CQ33703293-A3F72C9A-952F-4521-BC5F-F97790839F61Q33750165-CB15089F-B84D-4B1F-B212-5BC0F1E9AA7EQ34038395-DF786102-E15C-4F9C-B9C7-61C44B334154Q34334159-548B4513-66A2-40DE-8020-2E1BE4705BAFQ34447273-5CE4135D-C3E2-42BB-A0A9-3373D6B52A4DQ35189443-AA3FE2D9-EEA1-4751-BF33-6F3EABBF59CCQ35719862-02D16921-1652-417B-BCE3-6C15C1D24661Q35878429-295690AF-6367-437F-A9FF-9132FA20B924Q35956986-F8E1993D-2D58-415C-85E8-3B0F46315B67Q36288745-6C02551B-7F66-436A-9595-6C636D139E1DQ36315707-9D413AF2-069A-4F48-AA01-BA64698EA175Q36545926-B640D9AA-7002-41C2-9925-0E86635F3FC8Q37262447-5E80294D-CAAD-4420-B9F0-E7F677406689Q37269463-8660C669-A7CD-4A64-87CE-2741DB7EEC53Q37304764-1DDA0F07-9842-42E0-9F4C-C8BD97B8B48EQ37438076-11B6956D-7605-4CCA-8486-25371070C741Q37536500-8DDDA8EF-C9F2-46AC-B49D-A0C7EE5396A2Q37605645-7E7D422E-3022-413A-9136-671B2E1791AEQ37687393-66FA6677-BC0A-49E1-A1AF-041B89B27E7DQ37690966-B4083BFC-2830-49CE-8E0F-AEB7F913CECFQ37736572-1C0CF91D-551A-42D3-9ADA-58AC2BDA6DEFQ38175844-A4E21D3F-8FEA-406F-8C2D-0747410002D2Q38712750-72750B59-1669-4452-899C-7DE0379A3A48Q38726515-0F0CB0B8-4B16-4916-8377-8C5B33309DE6Q38875037-2137B568-7AC4-4DF3-803F-5592D48D22C9Q38887164-C6705C55-92EA-40CF-BB14-CDDA88F306BEQ41194394-9CEEFC82-2F2E-4D4A-9ECC-EDBE9411238FQ41320378-F19BE6AC-4370-4747-AB3A-96828BD4EE2AQ42805535-5E8CE4C8-C231-4B30-A8B6-08DCD9B6C594Q46349486-B51FFD33-7076-4703-BE57-C18BC83A8723Q47107525-6D46EA59-6F6C-451E-B509-F0E63CF422A3Q47250599-2FD4B7EF-44D2-492C-B275-308DBF4E7D70Q47311101-FED56565-2CAC-40D1-92A6-BB19C0F3C3A4Q52730161-6395C67B-FFD5-4989-A60E-8ACE8999F3C1
P2860
Molecular basis of triple negative breast cancer and implications for therapy.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Molecular basis of triple negative breast cancer and implications for therapy.
@ast
Molecular basis of triple negative breast cancer and implications for therapy.
@en
type
label
Molecular basis of triple negative breast cancer and implications for therapy.
@ast
Molecular basis of triple negative breast cancer and implications for therapy.
@en
prefLabel
Molecular basis of triple negative breast cancer and implications for therapy.
@ast
Molecular basis of triple negative breast cancer and implications for therapy.
@en
P2093
P2860
P356
P1476
Molecular basis of triple negative breast cancer and implications for therapy.
@en
P2093
Cynthia Ma
Matthew J Ellis
Parvin F Peddi
P2860
P304
P356
10.1155/2012/217185
P577
2011-11-02T00:00:00Z